Kestra Advisory Services’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-5,053
| Closed | -$454K | – | 2646 |
|
|
2024
Q3 | $454K | Sell |
5,053
-75
| -1% | -$6.74K | ﹤0.01% | 1817 |
|
|
2024
Q2 | $413K | Sell |
5,128
-2,657
| -34% | -$214K | ﹤0.01% | 1897 |
|
|
2024
Q1 | $621K | Buy |
7,785
+1,691
| +28% | +$135K | ﹤0.01% | 1522 |
|
|
2023
Q4 | $485K | Sell |
6,094
-1,802
| -23% | -$143K | ﹤0.01% | 1550 |
|
|
2023
Q3 | $552K | Sell |
7,896
-1,592
| -17% | -$111K | 0.01% | 1318 |
|
|
2023
Q2 | $682K | Sell |
9,488
-314
| -3% | -$22.6K | 0.01% | 1167 |
|
|
2023
Q1 | $605K | Buy |
9,802
+1,719
| +21% | +$106K | 0.01% | 1184 |
|
|
2022
Q4 | $623K | Sell |
8,083
-2,134
| -21% | -$165K | 0.01% | 1270 |
|
|
2022
Q3 | $456K | Sell |
10,217
-3,952
| -28% | -$176K | ﹤0.01% | 1373 |
|
|
2022
Q2 | $543K | Buy |
14,169
+4,574
| +48% | +$175K | 0.01% | 1289 |
|
|
2022
Q1 | $397K | Buy |
9,595
+3,341
| +53% | +$138K | ﹤0.01% | 1416 |
|
|
2021
Q4 | $236K | Sell |
6,254
-130
| -2% | -$4.91K | ﹤0.01% | 1772 |
|
|
2021
Q3 | $210K | Buy |
6,384
+784
| +14% | +$25.8K | ﹤0.01% | 1947 |
|
|
2021
Q2 | $378K | Buy |
5,600
+1,627
| +41% | +$110K | ﹤0.01% | 1428 |
|
|
2021
Q1 | $225K | Buy |
+3,973
| New | +$225K | ﹤0.01% | 1656 |
|